The objective of the trial is to assess the long-term safety and efficacy of L-CsA plus Standard of Care (SoC) in the treatment of BOS in single (SLT) and double lung transplant (DLT) recipients.
- Investigator
- Amir M Emtiazjoo
- Status
- Accepting Candidates
- Ages
- 18 Years - N/A
- Sexes
- All